80
Views
23
CrossRef citations to date
0
Altmetric
Original Research

DcR3 induces proliferation, migration, invasion, and EMT in gastric cancer cells via the PI3K/AKT/GSK-3β/β-catenin signaling pathway

, , , , , & show all
Pages 4177-4187 | Published online: 19 Jul 2018

References

  • JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
  • FockKMReview article: the epidemiology and prevention of gastric cancerAliment Pharmacol Ther201440325026024912650
  • ChafferCLWeinbergRAA perspective on cancer cell metastasisScience201133160241559156421436443
  • ThieryJPSleemanJPComplex networks orchestrate epithelial-mesenchymal transitionsNat Rev Mol Cell Biol20067213114216493418
  • KongDLiYWangZSarkarFHCancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins?Cancers20113171672921643534
  • Prieto-GarcíaEDíaz-GarcíaCVGarcía-RuizIAgulló-OrtuñoMTEpithelial-to-mesenchymal transition in tumor progressionMed Oncol20173412228560682
  • Benham-PyleBWPruittBLNelsonWJCell adhesion. Mechanical strain induces E-cadherin-dependent Yap1 and β-catenin activation to drive cell cycle entryScience201534862381024102726023140
  • PittiRMMarstersSALawrenceDAGenomic amplification of a decoy receptor for Fas ligand in lung and colon cancerNature199839667126997039872321
  • YuKYKwonBNiJZhaiYEbnerRKwonBSA newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosisJ Biol Chem199927420137331373610318773
  • MigoneTSZhangJLuoXTL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulatorImmunity200216347949211911831
  • LinWWHsiehSLDecoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancerBiochem Pharmacol201181783884721295012
  • LiuYPZhuHFLiuDLDcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRCOncotarget2016747773067731827764793
  • ZhangHChenXLiDDcR3 promotes hepatoma cell migration by downregulating E-cadherin expressionOncol Rep201738137738328560426
  • WuYGuoEYuJXieQHigh DcR3 expression predicts stage pN2-3 in gastric cancerAm J Clin Oncol2008311798318376232
  • LiangQLWangBRLiGHGhLDcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parametersJ Zhejiang Univ Sci B200910967568219735100
  • ChenCZhangCZhuangGDecoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) developmentCancer Invest2008261096597419093253
  • WuQZhengYChenDLiXLuCZhangZAberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesisJ Surg Res2014188245946524612949
  • YamanaKBilimVHaraNPrognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progressionBr J Cancer200593554455116091761
  • TongJAoRWangYChangBWangBYPrognostic and clinicopathological differences of DcR3 in gastrointestinal cancer: evidence from meta-analysisInt J Clin Exp Med2014793096310525356187
  • JiangMLinXHeRDecoy receptor 3 (DcR3) as a biomarker of tumor deterioration in female reproductive cancers: a meta-analysisMed Sci Monit2016221850185727246752
  • GeHLiangCRenSYueCWuJPrognostic value of DcR3 in solid tumors: a meta-analysisClin Chim Acta201848112613129499202
  • YuWXuYCTaoYDcR3 regulates the growth and metastatic potential of SW480 colon cancer cellsOncol Rep20133062741274824101127
  • ZhouXNLiGMXuYCZhaoTJWuJXKnockdown of decoy receptor 3 impairs growth and invasiveness of hepatocellular carcinoma cell line of HepG2Chin Med J2016129212623262927779171
  • LiangCXuYLiGDownregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosisOnco Targets Ther20171041742828176915
  • ArveloFSojoFCotteCTumour progression and metastasisEcancermedicalscience20161061726913068
  • ThompsonEWNewgreenDFTarinDCarcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?Cancer Res200565145991599516024595
  • MacdonaldBTTamaiKHeXWnt/beta-catenin signaling: components, mechanisms, and diseasesDev Cell200917192619619488
  • MartiniMde SantisMCBracciniLGulluniFHirschEPI3K/AKT signaling pathway and cancer: an updated reviewAnn Med201446637238324897931
  • ZhangYHuangSLengYEffect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKTOnco Targets Ther201695195520227621648
  • TodaMKawamotoTUehaT‘Decoy’ and ‘non-decoy’ functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cellsInt J Oncol201343370371223817777
  • ChenPHYangCRDecoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathwayJ Immunol2008181128441844919050262
  • HoCHHsuCFFongPFEpstein-Barr virus transcription activator Rta upregulates decoy receptor 3 expression by binding to its promoterJ Virol20078194837484717301127